Frederick M. Lang

TumorFusions: an integrative resource for cancer-associated transcript fusions

Ming Tang, Xin Hu, Emmanuel Martinez, 2017, Nucleic Acids Res..

TumorFusions: an integrative resource for reporting cancer-associated transcript fusions in 33 tumor types

Soo Hyun Lee, Frederick M. Lang, R. Verhaak, 2017, bioRxiv.

Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting

Frederick M. Lang, K. Aldape, H. Colman, 2015, Oncotarget.

Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma.

Frederick M. Lang, Jianping Zhang, X. Su, 2015, Neuro-oncology.

GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches

Frederick M. Lang, B. Becher, J. Hamilton, 2020, Nature Reviews Immunology.

Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas

Frederick M. Lang, J. Gumin, F. Lang, 2018, Neuro-oncology.